Helix BioPharma Corp. Opens the Market
26 Maggio 2016 - 4:59PM
PR Newswire (Canada)
TORONTO, May 26, 2016 /CNW/ - Dr. Sven Rohmann, CEO and President, Helix BioPharma
Corp. (HBP), joined Richard Rohan,
VP, Corporate Sales, TMX Equity Transfer & Trust Company, to
open the market to celebrate 20 years listed on Toronto Stock
Exchange. Helix BioPharma Corp. is a biopharmaceutical company
specializing in the development and commercialization of medicines
in the areas of cancer prevention and treatment. Helix BioPharma
Corp. commenced trading on Toronto Stock Exchange on June 3, 1996.
SOURCE TMX Group Limited
Copyright 2016 Canada NewsWire
Grafico Azioni Helix BioPharma (TSX:HBP)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Helix BioPharma (TSX:HBP)
Storico
Da Giu 2023 a Giu 2024
